Welcome to our dedicated page for Inspira Technologies Oxy Bhn news (Ticker: IINN), a resource for investors and traders seeking the latest updates and insights on Inspira Technologies Oxy Bhn stock.
Inspira Technologies Oxy B.H.N. Ltd. reports developments in Additively Manufactured Electronics, quantum connectivity and its medical technology portfolio. Company updates focus on AME system orders and deployments, QTREX-branded cryogenic interconnect work for superconducting quantum systems, customer activity with research, defense and technology organizations, and leadership or strategic-direction announcements.
The company's medical technology context includes respiratory support and blood monitoring platforms, including INSPIRA ART, INSPIRA ART100 and the HYLA Blood Sensor, while recent communications emphasize a dedicated medical business unit alongside the AME and quantum connectivity strategy.
Inspira Technologies (NASDAQ:IINN) outlined a three-track plan focused on an AME electronics platform, quantum computing connectivity and monetization of its medical business. The company acquired Nano Dimension’s AME platform, signed a joint development deal with Qarakal Quantum, and reported over $1 million in recent AME transactions.
Management is reducing the legacy medical burn rate and exploring sales of medical assets by Q3 2026 to generate non-dilutive capital. FDA-cleared ART100 has treated 40+ patients, and HYLA is being prepared for FDA submission. Shareholders approved a name change to QTREX Quantum.
Inspira (Nasdaq: IINN) secured a $596,000 purchase order for an Additively Manufactured Electronics (AME) system from a leading Irish technological research university on May 1, 2026.
The order includes a 40% non-refundable upfront payment already received, with the balance due on delivery. Inspira expects delivery in the coming weeks, training for research teams, and recurring revenue from proprietary consumables, wear parts, and annual service fees tied to system usage. The installation is intended as a reference site for further academic and commercial engagements across Europe.
Inspira (Nasdaq: IINN) signed a Joint Development Agreement with Qarakal Quantum to test Inspira’s QTREX additively manufactured electronics in superconducting, cryogenic environments. The multi‑phase program will supply 3D‑printed conductive and insulating structures for milli‑Kelvin testing, with metrics, scope, timelines, and resource commitments to be finalized.
The collaboration targets high‑density routing, integrated transitions, embedded shielding, rigid‑flex monolithics, and more compact interconnect geometries to address cryogenic signal‑connectivity scaling challenges in superconducting quantum systems.
Inspira Technologies (Nasdaq: IINN) received a fully paid $390,000 purchase order for an additive manufacturing electronics (AME) system from a premier APAC technological research university focused on quantum computing. The order also establishes a recurring revenue stream from consumables and fixed annual service fees. Inspira will deliver and deploy the AME system in the coming weeks and provide advanced application training for the university's research teams.
Inspira (Nasdaq: IINN) announced completion of commercial deployment of its Additively Manufactured Electronics (AME) system at a Tier‑1 U.S. defense customer on April 16, 2026. The delivery includes ongoing supply of proprietary consumables, creating a contractual basis for recurring revenue beyond the initial system sale.
The AME platform targets extreme miniaturization and complex integration needs across quantum computing, integrated photonics, and superconducting systems, and the company cites the deployment as evidence of commercial demand in advanced defense operations.
Inspira Technologies (NASDAQ: IINN) appointed Yoav Rozanovich as Chief Business Officer on April 14, 2026 to accelerate commercial execution after acquiring the Additive Manufacturing of Electronics (AME) business from Nano Dimension. Immediate priorities include integrating active AME revenue streams, driving AME sales conversion, and building quantum connectivity commercial pipelines.
Inspira (Nasdaq: IINN) announced on April 13, 2026 the start of an AME technology implementation with a customer described as one of the world's 10 largest U.S.-based companies. The rollout is already underway at a U.S. R&D facility and targets cryogenic connectivity for quantum computing using Inspira's acquired AME platform.
The company says this engagement validates the AME platform, reflects ongoing commercial activity with a top-tier technology customer, and supports recurring revenue prospects and broader demand from elite technology organizations.
Inspira (Nasdaq: IINN) is entering the quantum computing sector by directing its newly acquired additive manufactured electronics (AME) platform toward a 3D connectivity architecture for dilution cryostats. The company says the AME platform, developed with more than $200 million invested, has demonstrated proof of concept for qubit-related device integration.
Inspira intends to change its corporate name to QTREX Ltd. pending shareholder approval and is exploring collaborations while maintaining separate commercialization efforts for its medical products.
Inspira (Nasdaq: IINN) announced acquisition of Nano Dimension’s AME platform, acquiring intellectual property, high-precision 3D electronic printing systems, software, engineering know-how, equipment, inventory, customer-related assets and fully equipped facilities.
Total consideration is up to $12.5 million: a $2.0 million upfront cash payment and up to $10.5 million deferred payments tied to platform performance over the next 12 months; closing remains subject to customary regulatory approvals. Inspira assumed control effective immediately and will provide a further strategic update shortly.
Inspira Technologies (Nasdaq: IINN) has terminated its February 17, 2026 sales agreement with A.G.P./Alliance Global Partners and its December 12, 2025 Standby Equity Purchase Agreement with YA II PN, Ltd.
The company delivered formal written notices and stated there are no outstanding obligations or further advances under either agreement, citing a disciplined capital structure as it prepares for its next strategic phase.